Activation of a helper and not regulatory human CD4+ T cell response by oncolytic H-1 parvovirus.
BACKGROUND:H-1 parvovirus (H-1 PV), a rodent autonomous oncolytic parvovirus, has emerged as a novel class of promising anticancer agents, because of its ability to selectively find and destroy malignant cells. However, to probe H-1 PV multimodal antitumor potential one of the major prerequisites is...
Main Authors: | Olivier Moralès, Audrey Richard, Nathalie Martin, Dhafer Mrizak, Magalie Sénéchal, Céline Miroux, Véronique Pancré, Jean Rommelaere, Perrine Caillet-Fauquet, Yvan de Launoit, Nadira Delhem |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3281136?pdf=render |
Similar Items
-
Control of the Inflammatory Response Mechanisms Mediated by Natural and Induced Regulatory T-Cells in HCV-, HTLV-1-, and EBV-Associated Cancers
by: Laurissa Ouaguia, et al.
Published: (2014-01-01) -
Etude biochimique, chez E.Coli d'un mécanisme de réparation inductible et mutagène
by: Caillet Fauquet, Perrine
Published: (1976) -
Oncolytic virotherapy as emerging immunotherapeutic modality: potential of parvovirus H-1
by: Markus eMoehler, et al.
Published: (2014-05-01) -
Tumor selectivity of oncolytic parvoviruses: from in vitro and animal models to cancer patients
by: Assia L Angelova, et al.
Published: (2015-04-01) -
Immunotherapeutic Potential of Oncolytic H-1 Parvovirus: Hints of Glioblastoma Microenvironment Conversion towards Immunogenicity
by: Assia L. Angelova, et al.
Published: (2017-12-01)